BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10439953)

  • 1. [The pathogenetic characteristics and the possible ways for the pharmacological correction of insulin-dependent diabetes mellitus].
    Chernov IuN; Pashkov AN; Vasin MV; Batishcheva GA; Zolotarev DV
    Eksp Klin Farmakol; 1999; 62(3):60-6. PubMed ID: 10439953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects].
    Galenok VA; Zhuk EA
    Ter Arkh; 1995; 67(12):80-4. PubMed ID: 8820069
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin-dependent diabetes: a possible viral disease.
    Saggese G; Federico G; Garzelli C; Toniolo A
    Pediatrician; 1983-1985; 12(4):179-93. PubMed ID: 6100819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New thoughts on diabetes mellitus (author's transl)].
    Lenti G
    MMW Munch Med Wochenschr; 1977 May; 119(19):639-46. PubMed ID: 406546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
    Morrison EY; Ragoobirsingh D; Peter SA
    Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
    Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
    Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in diabetes mellitus.
    Johns Hopkins Med J; 1977 Jun; 140(6):331-6. PubMed ID: 405524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities of pharmacological hepatopathy and correction of fat metabolism violations in diabetes mellitus type 1].
    Semenova EV
    Eksp Klin Gastroenterol; 2009; (6):138-42. PubMed ID: 20201297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding insulin in day-to-day practice.
    Poole R; Krentz AJ
    Practitioner; 2001 Apr; 245(1621):324-6, 330, 332 passim. PubMed ID: 11332006
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of lipoproteins during insulin therapy in diabetes mellitus type 1].
    Pantelinac P
    Med Pregl; 2009; 62 Suppl 3():66-9. PubMed ID: 19702119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-acting insulin analogs: progressing slowly].
    Geelhoed-Duijvestijn PH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248; author reply 2248-9. PubMed ID: 15568634
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of insulin pumps for diabetes management.
    Webb KE
    Medsurg Nurs; 2006 Apr; 15(2):61-8, 94; quiz 69. PubMed ID: 16700243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern approaches to pharmacotherapy of diabetes mellitus type II].
    Kovel'man IR; Tochilkin AI; Beliaeva NF; Gorodetskiĭ VK; Kniazhev VA; Tkachenko SB; Semenov LL; Semenova NV
    Vopr Med Khim; 2002; 48(4):337-52. PubMed ID: 12506608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal hypoglycemia in patients with insulin-treated diabetes.
    Yale JF
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S41-6. PubMed ID: 15315870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetes mellitus type 1 (insulin-dependent). The etiopathogenetic aspects (II)].
    Guerra Vales JM; Damiano Rivero A
    Rev Clin Esp; 1995 Jul; 195(7):485-91. PubMed ID: 7667525
    [No Abstract]   [Full Text] [Related]  

  • 18. New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes.
    Crasto W; Jarvis J; Khunti K; Davies MJ
    Postgrad Med J; 2009 May; 85(1003):257-67. PubMed ID: 19520878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterisation of severe hypoglycaemia--a prospective population-based study.
    Holstein A; Plaschke A; Egberts EH
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):364-9. PubMed ID: 14520604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.